-
-
-
-
-
-
-
INSYS Therapeutics Provides Update on Strategic Alterative Review Process and Product Pipeline Spanning Pharmaceutical Cannabinoids and Spray Technology
-
-
-
-
-
-
-
Insys Therapeutics (INSY) Misses Q1 EPS by 1c
-
-
-
-
-
-
-
Insys Therapeutics (INSY) Misses Q3 EPS by 6c, Miss on Revenues
-
-
-
-
-
-
-
May 16 Deadline Alert: Tostrud Law Group, P.C. Reminds Investors of Upcoming Deadline in the Class Action Lawsuit Against Insys Therapeutics, Inc.
-
-
-
-
-
-
-
Insys Therapeutics (INSY) Delays Release of 4Q and FY16 Results; Audit Committee Conducting Independent Review
-
-
-
-
-
-
-
Insys Therapeutics (INSY) Misses Q2 EPS by 1c
-
-
-
-
-
-
-
Trading Radar for 4/28: Ford (F), Amazon (AMZN), Viacom (VIAB), LinkedIn (LNKD), Pandora (P), Aetna (AET) Report
-
1,197,449 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

